Recent HbA1C value-Above 7 Posts on Medivizor
Navigation Menu

Recent HbA1C value-Above 7 Posts on Medivizor

Comparing second-line therapy options combined with metformin for patients with type 2 diabetes.

Comparing second-line therapy options combined with metformin for patients with type 2 diabetes.

Posted by on Jul 25, 2021 in Diabetes mellitus | 0 comments

In a nutshell This study explored the effects of different second-line therapies combined with metformin (Glucophage) in patients with type 2 diabetes (T2D). The data showed that metformin combinations with a sulfonylurea (SU) had the lowest weight loss, the smallest effect of lowering blood glucose, and an overall, reduced health...

Read More

Evaluating the outcomes of cotadutide treatment for patients with type 2 diabetes

Evaluating the outcomes of cotadutide treatment for patients with type 2 diabetes

Posted by on Jul 11, 2021 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the outcomes of cotadutide (MEDI0382) treatment in patients with type 2 diabetes (T2D) and obesity. This study concluded that cotadutide treatment improved glycemic (blood sugar) control and weight loss in these patients. Some background T2D is commonly associated with obesity. About 70% of patients with T2D...

Read More

Is dapagliflozin add-on a good treatment option for patients with type 2 diabetes on insulin?

Is dapagliflozin add-on a good treatment option for patients with type 2 diabetes on insulin?

Posted by on Jun 13, 2021 in Diabetes mellitus | 0 comments

In a nutshell In this study, the authors evaluated the effectiveness of adding dapagliflozin (Farxiga) to insulin therapy in patients with uncontrolled type 2 diabetes (T2D). The study showed that compared to increasing insulin doses, dapagliflozin improved glucose control while reducing weight and hypoglycemia (dangerously low blood...

Read More

Can weekly semaglutide improve blood glucose in a real-world setting?

Can weekly semaglutide improve blood glucose in a real-world setting?

Posted by on May 23, 2021 in Diabetes mellitus | 0 comments

In a nutshell This study looked at how weekly semaglutide (Ozempic) affected patients with type 2 diabetes (T2D) in a real-world setting. It found that semaglutide improved blood sugar control compared to the treatments patients were already taking. Some background For patients with T2D, the body does not respond well to the hormone insulin, which...

Read More

Comparing effectiveness and safety of combined insulin aspart 30 and metformin compared to insulin aspart 30 alone in patients with type 2 diabetes and different heart disease risk profiles

Comparing effectiveness and safety of combined insulin aspart 30 and metformin compared to insulin aspart 30 alone in patients with type 2 diabetes and different heart disease risk profiles

Posted by on May 16, 2021 in Diabetes mellitus | 0 comments

In a nutshell This study compared the effectiveness and safety of biphasic insulin aspart 30 (BIAsp 30; NovoMix 30) alone or with metformin (Glucophage), in patients with inadequately controlled type 2 diabetes (T2D). The authors concluded that combined therapy may be preferred in patients with high cardiovascular risk and/or a body...

Read More

The effect of adding henagliflozin treatment to metformin in patients with type 2 diabetes.

The effect of adding henagliflozin treatment to metformin in patients with type 2 diabetes.

Posted by on May 9, 2021 in Diabetes mellitus | 0 comments

In a nutshell This study examined the effectiveness of adding henagliflozin (SHR3824) to metformin (Glucophage) in patients with uncontrolled type 2 diabetes (T2D). The authors concluded that the addition of 5 mg or 10 mg of henagliflozin to metformin was well-tolerated and effective in these patients.  Some background...

Read More

Can ertugliflozin improve diabetes and blood pressure in patients who have heart disease?

Can ertugliflozin improve diabetes and blood pressure in patients who have heart disease?

Posted by on May 6, 2021 in Diabetes mellitus | 0 comments

In a nutshell This study looked at the ertugliflozin (Steglatro) for patients with type 2 diabetes (T2D) and heart disease. It found that ertugliflozin improved both blood glucose control, body weight, and blood pressure. Some background T2D is a condition in which the levels of glucose (sugar) in the blood are too high. T2D is related to...

Read More

Comparing safety and effectiveness of liraglutide to insulin glargine after hospital discharge in patients with uncontrolled type 2 diabetes.

Comparing safety and effectiveness of liraglutide to insulin glargine after hospital discharge in patients with uncontrolled type 2 diabetes.

Posted by on Mar 28, 2021 in Diabetes mellitus | 0 comments

In a nutshell This study compared the safety and effectiveness of liraglutide (Victoza) to insulin glargine (Lantus) on glycemic (blood glucose) control in patients with type 2 diabetes (T2D) after hospital discharge. The authors concluded that liraglutide treatment led to improved glycemic control and greater weight loss compared to...

Read More

Which diabetic drug is safer for older patients with type 2 diabetes, linagliptin or glimepiride?

Which diabetic drug is safer for older patients with type 2 diabetes, linagliptin or glimepiride?

Posted by on Dec 13, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study compared the safety of two medications, linagliptin (Trajenta) and glimepiride (Amaryl). It found that the medications had the same risk of heart attack, stroke, or heart-related death, while linagliptin was associated with a lower risk of hypoglycemia (dangerously low blood glucose level). Some background There...

Read More